The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.
For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different ...
A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...
CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...
A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
Iovance chose Philadelphia for its manufacturing operations because of the region's proximity to airports and history of ...
CAR-T cell therapy puts woman's three autoimmune diseases into remission after single infusion when nine previous treatments ...
An update on CAR-T therapies for MM and B-cell NHL presented at the 2026 ONA Summit highlighted the integral role of oncology nurses in ensuring patients achieve optimal outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results